Clinical Trial Update: Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A phase 3 clinical trial comparing paclitaxel with or without gemcitabine in women with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED